Association of Healthy Lifestyle With Years Lived Without Major Chronic Diseases.


Journal

JAMA internal medicine
ISSN: 2168-6114
Titre abrégé: JAMA Intern Med
Pays: United States
ID NLM: 101589534

Informations de publication

Date de publication:
01 05 2020
Historique:
pubmed: 7 4 2020
medline: 21 1 2021
entrez: 7 4 2020
Statut: ppublish

Résumé

It is well established that selected lifestyle factors are individually associated with lower risk of chronic diseases, but how combinations of these factors are associated with disease-free life-years is unknown. To estimate the association between healthy lifestyle and the number of disease-free life-years. A prospective multicohort study, including 12 European studies as part of the Individual-Participant-Data Meta-analysis in Working Populations Consortium, was performed. Participants included 116 043 people free of major noncommunicable disease at baseline from August 7, 1991, to May 31, 2006. Data analysis was conducted from May 22, 2018, to January 21, 2020. Four baseline lifestyle factors (smoking, body mass index, physical activity, and alcohol consumption) were each allocated a score based on risk status: optimal (2 points), intermediate (1 point), or poor (0 points) resulting in an aggregated lifestyle score ranging from 0 (worst) to 8 (best). Sixteen lifestyle profiles were constructed from combinations of these risk factors. The number of years between ages 40 and 75 years without chronic disease, including type 2 diabetes, coronary heart disease, stroke, cancer, asthma, and chronic obstructive pulmonary disease. Of the 116 043 people included in the analysis, the mean (SD) age was 43.7 (10.1) years and 70 911 were women (61.1%). During 1.45 million person-years at risk (mean follow-up, 12.5 years; range, 4.9-18.6 years), 17 383 participants developed at least 1 chronic disease. There was a linear association between overall healthy lifestyle score and the number of disease-free years, such that a 1-point improvement in the score was associated with an increase of 0.96 (95% CI, 0.83-1.08) disease-free years in men and 0.89 (95% CI, 0.75-1.02) years in women. Comparing the best lifestyle score with the worst lifestyle score was associated with 9.9 (95% CI 6.7-13.1) additional years without chronic diseases in men and 9.4 (95% CI 5.4-13.3) additional years in women (P < .001 for dose-response). All of the 4 lifestyle profiles that were associated with the highest number of disease-free years included a body-mass index less than 25 (calculated as weight in kilograms divided by height in meters squared) and at least 2 of the following factors: never smoking, physical activity, and moderate alcohol consumption. Participants with 1 of these lifestyle profiles reached age 70.3 (95% CI, 69.9-70.8) to 71.4 (95% CI, 70.9-72.0) years disease free depending on the profile and sex. In this multicohort analysis, various healthy lifestyle profiles appeared to be associated with gains in life-years without major chronic diseases.

Identifiants

pubmed: 32250383
pii: 2763720
doi: 10.1001/jamainternmed.2020.0618
pmc: PMC7136858
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

760-768

Subventions

Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P023444/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRC S011676
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG034454
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056477
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Circulation. 2018 Jul 24;138(4):345-355
pubmed: 29712712
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
PLoS Med. 2009 Apr 28;6(4):e1000058
pubmed: 19399161
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Thorax. 2016 Jan;71(1):84-5
pubmed: 26253581
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Scand J Med Sci Sports. 2006 Feb;16 Suppl 1:3-63
pubmed: 16451303
Obes Rev. 2007 Mar;8 Suppl 1:13-7
pubmed: 17316295
Am J Epidemiol. 2012 Dec 15;176(12):1078-89
pubmed: 23144364
Epidemiology. 2014 Nov;25(6):932-3
pubmed: 25265141
Lancet. 2012 Oct 27;380(9852):1491-7
pubmed: 22981903
Cancer. 2011 Feb 15;117(4):714-22
pubmed: 20882563
CMAJ. 2006 Mar 14;174(6):801-9
pubmed: 16534088
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
BMC Med. 2015 Feb 27;13:39
pubmed: 25858161
Am J Epidemiol. 2019 May 1;188(5):907-916
pubmed: 30877760
Arch Intern Med. 2010 Apr 26;170(8):711-8
pubmed: 20421558
Lancet Public Health. 2018 Oct;3(10):e490-e497
pubmed: 30177479
PLoS One. 2012;7(7):e40101
pubmed: 22792218
J Intern Med. 2012 Jul;272(1):65-73
pubmed: 22077620
Int J Epidemiol. 2019 Jun 1;48(3):899-907
pubmed: 31005996
PLoS One. 2012;7(7):e35463
pubmed: 22792154
Lancet Diabetes Endocrinol. 2018 Mar;6(3):223-236
pubmed: 28919064
Stat Med. 2002 Aug 15;21(15):2175-97
pubmed: 12210632
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959
pubmed: 24239921
PLoS Med. 2019 Feb 4;16(2):e1002741
pubmed: 30716101
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Am J Public Health. 2013 Nov;103(11):2090-7
pubmed: 23678931
Int J Epidemiol. 2016 Aug;45(4):1260-1270
pubmed: 27488415

Auteurs

Solja T Nyberg (ST)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Archana Singh-Manoux (A)

Department of Epidemiology and Public Health, University College London, London, United Kingdom.
Inserm U1153, Epidemiology of Ageing and Neurodegenrative Diseases, Paris, France.

Jaana Pentti (J)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Department of Public Health, University of Turku, Turku University Hospital, Turku, Finland.
Centre for Population Health Research, University of Turku, Turku University Hospital, Turku, Finland.

Ida E H Madsen (IEH)

National Research Centre for the Working Environment, Copenhagen, Denmark.

Severine Sabia (S)

Department of Epidemiology and Public Health, University College London, London, United Kingdom.
Inserm U1153, Epidemiology of Ageing and Neurodegenrative Diseases, Paris, France.

Lars Alfredsson (L)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Centre for Occupational and Environmental Medicine, Stockholm County Council, Stockholm, Sweden.

Jakob B Bjorner (JB)

National Research Centre for the Working Environment, Copenhagen, Denmark.

Marianne Borritz (M)

Bispebjerg University Hospital, Copenhagen, Denmark.

Hermann Burr (H)

Federal Institute for Occupational Safety and Health, Berlin, Germany.

Marcel Goldberg (M)

Faculty of Medicine, Paris Descartes University, Paris, France.
Inserm UMS 011, Population-Based Epidemiological Cohorts Unit, Villejuif, France.

Katriina Heikkilä (K)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Markus Jokela (M)

Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Anders Knutsson (A)

Department of Health Sciences, Mid Sweden University, Sundsvall, Sweden.

Tea Lallukka (T)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Finnish Institute of Occupational Health, Helsinki, Finland.

Joni V Lindbohm (JV)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Martin L Nielsen (ML)

AS3 Employment, AS3 Companies, Viby J, Denmark.

Maria Nordin (M)

Stress Research Institute, Stockholm University, Stockholm, Sweden.
Department of Psychology, Umeå University, Umeå, Sweden.

Tuula Oksanen (T)

Finnish Institute of Occupational Health, Helsinki, Finland.

Jan H Pejtersen (JH)

VIVE-The Danish Center for Social Science Research, Copenhagen, Denmark.

Ossi Rahkonen (O)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Reiner Rugulies (R)

National Research Centre for the Working Environment, Copenhagen, Denmark.
Department of Public Health and Department of Psychology, University of Copenhagen, Copenhagen, Denmark.

Martin J Shipley (MJ)

Department of Epidemiology and Public Health, University College London, London, United Kingdom.

Pyry N Sipilä (PN)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Sari Stenholm (S)

Department of Public Health, University of Turku, Turku University Hospital, Turku, Finland.
Centre for Population Health Research, University of Turku, Turku University Hospital, Turku, Finland.

Sakari Suominen (S)

Department of Public Health, University of Turku, Turku University Hospital, Turku, Finland.
University of Skövde, School of Health and Education, Skövde, Sweden.

Jussi Vahtera (J)

Department of Public Health, University of Turku, Turku University Hospital, Turku, Finland.
Centre for Population Health Research, University of Turku, Turku University Hospital, Turku, Finland.

Marianna Virtanen (M)

School of Educational Sciences and Psychology, University of Eastern Finland, Joensuu, Finland.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Hugo Westerlund (H)

Stress Research Institute, Stockholm University, Stockholm, Sweden.

Marie Zins (M)

Faculty of Medicine, Paris Descartes University, Paris, France.
Inserm UMS 011, Population-Based Epidemiological Cohorts Unit, Villejuif, France.

Mark Hamer (M)

Division of Surgery & Interventional Science, Faculty of Medical Sciences, University College London, London, United Kingdom.

G David Batty (GD)

Department of Epidemiology and Public Health, University College London, London, United Kingdom.
School of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon.

Mika Kivimäki (M)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Department of Epidemiology and Public Health, University College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH